| Financial Year |
March 31 2023 |
| Monetary Funds |
705,748,366.27 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
650,671.78 |
| Accounts Receivable |
1,029,625,334.63 |
| Advances to Suppliers |
94,152,072.66 |
| Other Receivables |
123,456,542.79 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
56,965,504.33 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
1,981,121.58 |
| Other Current Assets |
3,835,432.89 |
| Total Current Assets |
2,024,241,656.79 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
11,419,637.02 |
| Long-term Equity Investment |
7,845,677.27 |
| Investment Properties |
-- |
| Fixed Assetes |
88,085,243.08 |
| Under-construction Projects |
200,816,248.02 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
76,930,462.57 |
| R&D expenses |
21,673,581.18 |
| Goodwill |
162,742,283.36 |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
31,392,448.25 |
| Other Non-Current Assets |
11,293,196.58 |
| Sub-Total of Non-Current Assets |
624,417,419.86 |
| Total Assets |
2,648,659,076.65 |
| Short-Term Loans |
529,410,868.81 |
| Trading Financial liabilities |
-- |
| Notes Payable |
471,808,234.62 |
| Accounts Payable |
134,184,377.55 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
23,426,979.56 |
| Taxes Payable |
89,959,451.78 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
34,232,939.27 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
72,777,700.51 |
| Other Current Liabilities |
5,240,937.98 |
| Sub-Total of Current Liabilities |
1,372,070,102.16 |
| Long-term Loans |
112,980,800.19 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
5,542,965.89 |
| Other Non-Current Liabilities |
466,128.53 |
| Sub-Total of Non-Current Liabilities |
119,686,814.04 |
| Total Liabilities |
1,491,756,916.20 |
| Paid-In Capital(Or Share Stock) |
227,814,392.00 |
| Capital Surplus |
429,066,204.99 |
| Surplus Reserve |
45,344,678.76 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
430,504,947.81 |
| Minority Stockholder's Interest |
25,706,414.63 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,131,195,745.82 |
| Owner's Equity（Stockholder's Equity） |
1,156,902,160.45 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,648,659,076.65 |
